Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/<i>β</i>-Cyclodextrin Nanocomposition against  Androgen Receptor-Negative Prostate Cancers

<table>Microphoto of control ML after 18 h. coincubation with K-562 (×100). MTT added.</table>

International Scholarly Research Notices

fig5

Figure 5

Figure 5: Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/<i>β</i>-Cyclodextrin Nanocomposition against  Androgen Receptor-Negative Prostate Cancers 

Figure 5 | Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/β-Cyclodextrin Nanocomposition against  Androgen Receptor-Negative Prostate Cancers 